Browsing "1. Journal Papers" by Author : 5682

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 43 of 43

This table browses all dspace content
Issue DateTitleJournal Title
2021A diagnostic tree for differentiation of adult pilocytic astrocytomas from high-grade gliomasEUROPEAN JOURNAL OF RADIOLOGY
2022A fully automatic multiparametric radiomics model for differentiation of adult pilocytic astrocytomas from high-grade gliomasEUROPEAN RADIOLOGY
2022Adding radiomics to the 2021 WHO updates may improve prognostic prediction for current IDH-wildtype histological lower-grade gliomas with known EGFR amplification and TERT promoter mutation statusEUROPEAN RADIOLOGY
2022An interpretable radiomics model to select patients for radiotherapy after surgery for WHO grade 2 meningiomas RADIATION ONCOLOGY
2021Biochemical Remission after Cabergoline Withdrawal in Hyperprolactinemic Patients with Visible Remnant Pituitary AdenomaJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
2022Clinical and diffusion parameters may noninvasively predict TERT promoter mutation status in grade II meningiomasJOURNAL OF NEURORADIOLOGY
2022Clinical factors and conventional MRI may independently predict progression-free survival and overall survival in adult pilocytic astrocytomasNEURORADIOLOGY
2024Clinical, qualitative imaging biomarkers, and tumor oxygenation imaging biomarkers for differentiation of midline-located IDH wild-type glioblastomas and H3 K27-altered diffuse midline gliomas in adultsEUROPEAN JOURNAL OF RADIOLOGY
2018Comparison of 3D Volumetric Subtraction Technique and 2D Dynamic Contrast Enhancement Technique in the Evaluation of Contrast Enhancement for Diagnosing Cushing's Disease Investigative Magnetic Resonance Imaging
2020Comparison of Diagnostic Performance of Two-Dimensional and Three-Dimensional Fractal Dimension and Lacunarity Analyses for Predicting the Meningioma Grade Brain Tumor Research and Treatment
2021Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parametersNEURORADIOLOGY
2021Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation SCIENTIFIC REPORTS
2020Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomasEUROPEAN RADIOLOGY
2021Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancerNEURORADIOLOGY
2021Dynamic contrast-enhanced MRI may be helpful to predict response and prognosis after bevacizumab treatment in patients with recurrent high-grade glioma: comparison with diffusion tensor and dynamic susceptibility contrast imagingNEURORADIOLOGY
2023Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtypeJOURNAL OF NEURO-ONCOLOGY
2021Efficacy and Cerebrospinal Fluid Rhinorrhea after Cabergoline Treatment in Patients with Bioactive Macroprolactinoma CANCERS
2024High Radiation Dose to the Fornix Causes Symptomatic Radiation Necrosis in Patients with Anaplastic Oligodendroglioma YONSEI MEDICAL JOURNAL
2021Identification of magnetic resonance imaging features for the prediction of molecular profiles of newly diagnosed glioblastomaJOURNAL OF NEURO-ONCOLOGY
2021Magnetic Resonance Imaging Parameters for Noninvasive Prediction of Epidermal Growth Factor Receptor Amplification in Isocitrate Dehydrogenase-Wild-Type Lower-Grade Gliomas: A Multicenter StudyNEUROSURGERY
2020Magnetic resonance imaging-based 3-dimensional fractal dimension and lacunarity analyses may predict the meningioma gradeEUROPEAN RADIOLOGY
2020MR image phenotypes may add prognostic value to clinical features in IDH wild-type lower-grade gliomasEUROPEAN RADIOLOGY
2021MRI Features May Predict Molecular Features of Glioblastoma in Isocitrate Dehydrogenase Wild-Type Lower-Grade GliomasAMERICAN JOURNAL OF NEURORADIOLOGY
2018Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade GliomasAMERICAN JOURNAL OF NEURORADIOLOGY
2023Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study KOREAN JOURNAL OF RADIOLOGY
2021Quality assessment of meningioma radiomics studies: Bridging the gap between exploratory research and clinical applicationsEUROPEAN JOURNAL OF RADIOLOGY
2022Quality of Radiomics Research on Brain Metastasis: A Roadmap to Promote Clinical Translation KOREAN JOURNAL OF RADIOLOGY
2022Quality reporting of radiomics analysis in pituitary adenomas: promoting clinical translationBRITISH JOURNAL OF RADIOLOGY
2021Radiomics and Deep Learning in Brain Metastases: Current Trends and Roadmap to Future Applications Investigative Magnetic Resonance Imaging
2019Radiomics and machine learning may accurately predict the grade and histological subtype in meningiomas using conventional and diffusion tensor imagingEuropean Radiology
2020Radiomics model predicts granulation pattern in growth hormone-secreting pituitary adenomasPITUITARY
2019Radiomics MRI Phenotyping with Machine Learning to Predict the Grade of Lower-Grade Gliomas: A Study Focused on Nonenhancing Tumors Korean Journal of Radiology
2020Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomasEUROPEAN RADIOLOGY
2021Radiomics With Ensemble Machine Learning Predicts Dopamine Agonist Response in Patients With ProlactinomaJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
2024Rethinking extent of resection of contrast-enhancing and non-enhaning tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classificationEUROPEAN RADIOLOGY
2022Revisiting growth hormone nadir cut-offs for remission in patients with acromegalyEUROPEAN JOURNAL OF ENDOCRINOLOGY
2023Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities JOURNAL OF NEURO-ONCOLOGY
2022Sex as a prognostic factor in adult-type diffuse gliomas: an intergrated clinical and molecular analysis according to the 2021 WHO classificationJOURNAL OF NEURO-ONCOLOGY
2023The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse GliomasJOURNAL OF MAGNETIC RESONANCE IMAGING
2023The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 2-Summary of Imaging Findings on Pediatric-Type Diffuse High-Grade Gliomas, Pediatric-Type Diffuse Low-Grade Gliomas, and Circumscribed Astrocytic GliomasJOURNAL OF MAGNETIC RESONANCE IMAGING
2023The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 3-Summary of Imaging Findings on Glioneuronal and Neuronal TumorsJOURNAL OF MAGNETIC RESONANCE IMAGING
2022Three-dimensional fractal dimension and lacunarity features may noninvasively predict TERT promoter mutation status in grade 2 meningiomas PLOS ONE
2018Whole-Tumor Histogram and Texture Analyses of DTI for Evaluation of IDH1-Mutation and 1p/19q-Codeletion Status in World Health Organization Grade II GliomasAMERICAN JOURNAL OF NEURORADIOLOGY
1

Browse

Links